Lupin 2024

IQVIA Institute issues new annual trend report

Print Friendly, PDF & Email

DANBURY, Conn. — IQVIA Institute has released its annual trend report on use of medicines in the U.S. The report, The Use of Medicines in the U.S. 2022 , is intended to provide a grounding in relevant information across a range of issues with both short- and long-term implications. It includes the Health Services Utilization Index, which tracks a range of healthcare activities that affect the use of medicines.

Key findings in the report include:
  • Spending on U.S. medicines rose 12% in 2021 due primarily to COVID-19 vaccines and therapies
  • Despite an increase in overall spending, costs per prescription on average are flat or slightly declining
  • Prescription drug use reached a record 194Bn daily doses in 2021 as new prescription starts for both chronic and acute care recovered from the slowdown recorded in 2020
  • Health services utilization returned to pre-pandemic levels by the end of 2021 but has yet to make up for the pandemic-induced backlog in missed patient visits, screenings and diagnostics, elective procedures, and new prescription starts
  • Spending on medicines is expected to return to pre-pandemic growth trend lines by 2023

ECRM_06-01-22


Comments are closed.

PP_1170x120_10-25-21